Medical Developments International | MVP - Ebitda

Stock Price
0.42
Daily Change
0.01 2.44%
Monthly
0%
Yearly
-7.69%
Q2 Forecast
0.40

Medical Developments International reported AUD1.78M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Genetic Signatures AUD -7.11M 970K Dec/2024
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025
Viatris USD 1B 151.5M Dec/2025
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025